This trial is completed!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
Rectal Neoplasms
and you are
This is a second phase trial assessing
efficacy and side effects of the new treatment.
Show me locations

The purpose

Radiotherapy (RT) is a potentially effective method in the treatment of symptoms of rectal carcinomas. Nevertheless, almost all the evidences about palliative RT in rectal cancer have been published more than two decades ago and were based on 2D conventional RT, which is nowadays no longer used. Consequently, prospective studies on the efficacy of 3D-RT in the management of symptomatic rectal cancer are still lacking. The aim of this prospective study was to assess the efficacy of palliative short-course 3D RT (SCRT) in patients with symptomatic obstructive rectal cancer.

Provided treatments

  • Radiation: Conformal three-dimensional Radiotherapy

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT02639403. The sponsor of the trial is Azienda Ospedaliera Universitaria di Bologna Policlinico S. Orsola Malpighi and it is looking for 18 volunteers for the current phase.
Official trial title:
Palliative Short-Course Radiotherapy in Rectal Cancer: A Phase II Study